Beloranib
Beloranib is a former drug candidate for the treatment of obesity. It was discovered by CKD Pharmaceuticals and its clinical development was led by Zafgen. Drug development was halted in 2016 after deaths during clinical trials.
Link from a Wikipage to another Wikipage
primaryTopic
Beloranib
Beloranib is a former drug candidate for the treatment of obesity. It was discovered by CKD Pharmaceuticals and its clinical development was led by Zafgen. Drug development was halted in 2016 after deaths during clinical trials.
has abstract
Beloranib is a former drug can ...... deaths during clinical trials.
@en
Beloranib é uma molécula em fa ...... rmacêutica dos Estados Unidos.
@pt
alternative name
CKD-732; ZGN-433
@en
IUPAC name
(3R,4S,5S,6R)-5-Methoxy-4-[(2R ...... no)ethoxy]phenyl}prop-2-enoate
@en
Wikipage page ID
32,539,904
page length (characters) of wiki page
Wikipage revision ID
1,025,407,635
Link from a Wikipage to another Wikipage
ImageFile
@en
imagesize
OtherNames
CKD-732; ZGN-433
@en
Verifiedfields
changed
@en
verifiedrevid
461,514,628
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
Beloranib is a former drug can ...... deaths during clinical trials.
@en
Beloranib é uma molécula em fa ...... rmacêutica dos Estados Unidos.
@pt
label
Beloranib
@en
Beloranib
@pt